PetVivo Holdings Inc. (PETV) reported its financial results for the third quarter of fiscal year 2025, showcasing a significant increase in revenues driven by its expanding distribution network.
Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...
Q3 2025 Earnings Call Transcript February 14, 2025 8:00 AM ETCompany ParticipantsAndrew Arnovitz - Senior VP, Investor Relations ...
Terumo Corporation ( OTCPK:TRUMF) Q3 2025 Earnings Conference Call February 13, 2025 3:00 AM ET [Call Starts Abruptly] Thank you for your kind introduction. I’m Hagimoto, Terumo’s CFO. This ...
India Inc registered a growth of 14 per cent in its net profit at Rs 3.37 lakh crore in the quarter ended December 2024, ...
Quarterly revenue of $935 million, above the midpoint of guidance Quarterly GAAP net income of $90 million and net income per diluted share of $1.33Quarterly Adjusted EBITDA of $237 million and Non-GA ...
A long bear candle was formed on the weekly chart, which indicates a reversal on the downside after the two weeks of upside ...
First American Financial Corporation (NYSE: FAF) Q4 2024 Earnings Call Transcript February 13, 2025 ...
The unsecured loans and microfinance segments, accounting for about 23% of the overall AUM of the industry, are expected to ...
For Ashok Leyland, margin expansion, driven by a better sales mix and pricing power, has boosted investor sentiment. With ...
Q3 2025 Earnings Call Feb 13, 2025, 1:35 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prep ...
Operating margins narrowed to 7.1%, down from 8% in the year-ago period, indicating margin pressures despite revenue growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results